intégrant la synthèse chimique et les permettre aux molécules de ses clients fonctions de l'entreprise : R&D, M&S, processus biologiques tout en respec- d'entrer avec succès sur le marché. Opérations, Approvisionnement, tant les normes internationales les plus Avec son réseau mondial de 11 sites Réglementation et Qualité. Olon Bio- strictes en matière de sécurité, de qua- de production et de 7 centres de R&D tech propose des services de dévelop- lité et d'environnement, Olon dispose à travers le monde, employant 2 300 pement et de fabrication sous contrat de l’un des plus longs palmarès de personnes, dont 300 experts en R&D (CDMO), ainsi que le développement, l'industrie des API et d’une expertise hautement expérimentés et qualifiés, il la fabrication et la vente de produits approfondie en matière de développe- représente un partenaire très innovant propriétaires (PP). ment et d’un large éventail de techno- et fiable. Division d’Olong Group, logies de pointe. Ce qui le positionne Olon Biotech s'appuie sur le soutien comme partenaire de choix pour fonctionnel et l'expertise de toutes les Ligne de fabrication d'Olon sur son site de Rodano, capable de traiter des composés hautement actifs Olon's production line at its Rodano site, able to process highly potent compounds operating under extremely stringent before packaging the final product. A fur- around the world, employing 2,300 containment conditions, dedicated enti- ther complexity arises from the need to people, including 300 gyeperienced rely to the development and production perform some operations in high contain- and qualified R&D experts, it is a highly of ultra-powerful APIs, payloads and ment facilities due to the toxicity of the innovative and reliable partner. A division payload links for ADCs), drawing on materials. of Olong Group, Olon Biotech draws on more than 40 years' experience in the A world leader in the development and the functional support and expertise of manufacture of cytotoxic products. With production of active pharmaceutical all the company's functions: R&D, M&S, the acquisition of GTP Bioways, Olon ingredients (APIs) for the CDMO and Operations, Supply Chain, Regulatory Biotech will be able to offer complete generic markets, integrating chemical and Quality. Olon Biotech offers contract services for the development and produc- synthesis and biological processes while development and manufacturing services tion of ADCs, capable of supplying mAbs complying with the strictest international (CDMO), as well as the development, to linkers, payloads, conjugation and fill safety, quality and environmental stan- manufacture and sale of proprietary pro- and finish. ADCs are an important new dards, Olon has one of the longest track ducts (PP). class of oncology treatments that com- records in the API industry and in-depth bine a tumour-targeting antibody with a development expertise and a wide range cell-destroying cytotoxic drug (payload). of cutting-edge technologies. This posi- Their development and manufacture are tions it as the partner of choice to enable complex tasks: development of a mono- its customers' molecules to enter the mar- clonal antibody (mAb) and a cytotoxic ket successfully. With its global network payload, which must then be conjugated, of 11 production sites and 7 R&D centres